Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $25.2900 (1.32%) ($24.8100 - $25.2900) on Mon. Sep. 27, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.14% (three month average) | RSI | 50 | Latest Price | $25.2900(1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.1% a day on average for past five trading days. | Weekly Trend | IOVA advances 2.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) IWO(40%) XBI(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.57% in a week (0% probabilities). VIXM(-24%) UUP(-15%) VXX(-11%) TBT(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.57% (StdDev 3.14%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $24.79(2.02%) | 10 Day Moving Average | $24.14(4.76%) | 20 Day Moving Average | $24.03(5.24%) | To recent high | -6.2% | To recent low | 23.2% | Market Cap | $3.703b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |